295466
Bilateral benefits of global health acts
Monday, November 4, 2013
: 9:15 a.m. - 9:30 a.m.
Health care in the USA is expensive, using many resources and tests not available in much of the world. A usual query in caring for patients or deciding protocol is why didn't you order/ do
?' We need to reconsider how useful all the evaluations are, how often they lead to more expenditure of resources, and how often they make a practical contribution to the patient's well being. Working as an American clinician in less developed countries forces one to question of the value of all tests, medications, advice or procedures to helping the patient ; the query always is why did you order/do
, does it make a difference to the patient's outcome?' One cannot treat the patient by laboratory results and algorithms. The benefit to patients in the USA of a healthcare provider who considers the costs and benefits to the patient's well being rather than the rules of procedure and possibility of legal entanglement could be considerable. Most of the discussion and examples will be based on years of work in rural Haiti. Working in resource poor areas is an important possibility for Americans to think and act both globally and locally to the benefit of all.
Learning Areas:
Basic medical science applied in public health
Public health or related education
Learning Objectives:
Discuss and understand problems of delivering health care in resource poor settings
List three benefits to providing health care in the USA from lessons learned in resource poor settings
Keyword(s): Access and Services, Community-Oriented Primary Care
Presenting author's disclosure statement:Qualified on the content I am responsible for because: I have over 40 years of working as a professor, physician and public health professional. i have presented nationally and internationally.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.